Skip to main content
Top
Published in: Surgery Today 4/2024

09-08-2023 | Fluconazole | Original Article

Surgical treatment for chronic pulmonary coccidioidomycosis: a retrospective study from a single institution

Authors: Hajime Tamura, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Terunaga Inage, Takamasa Ito, Kazuhisa Tanaka, Yuichi Sakairi, Hironobu Wada, Ichiro Yoshino

Published in: Surgery Today | Issue 4/2024

Login to get access

Abstract

Purpose

Coccidioidomycosis, caused by the Coccidioides species, is a well-known disease in the Southwestern United States and North Mexico, with scattered reports in Latin America countries. While this disease is still rare in Japan and other Asian countries, its incidence has been increasing over the last two decades. Coccidioides species are highly infectious and require caution when encountered. This study presents a case series of chronic pulmonary coccidioidomycosis surgically treated at a single institution.

Methods

We conducted a retrospective chart review of six patients who underwent lung resection for pulmonary coccidioidomycosis at Chiba University Hospital between January 2007 and December 2021.

Results

All six patients had travelled to the Southwestern United States. Preoperative serology was negative for the anti-Coccidioides antibody in four patients and positive in two. Chest computed tomography revealed a single, well-defined round nodule in all patients. Preoperative biopsy taken from three patients failed to obtain a definitive diagnosis. Histopathological examination of the resected pulmonary nodules revealed granulomas that contained numerous spherules with many endospores, thereby confirming the diagnosis of pulmonary coccidioidomycosis.

Conclusions

Pulmonary coccidioidomycosis should be suspected based on travel history and radiological findings. Meticulous care should be taken during specimen processing to prevent cross infection.
Literature
1.
go back to reference Hirschmann JV. The early history of coccidioidomycosis: 1892–1945. Clin Infect Dis. 2007;44:1202–7.CrossRefPubMed Hirschmann JV. The early history of coccidioidomycosis: 1892–1945. Clin Infect Dis. 2007;44:1202–7.CrossRefPubMed
2.
go back to reference Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73–84.CrossRefPubMed Fisher MC, Koenig GL, White TJ, Taylor JW. Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia. 2002;94:73–84.CrossRefPubMed
4.
go back to reference Brown J, Benedict K, Park BJ, Thompson GR 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;25:185–97. Brown J, Benedict K, Park BJ, Thompson GR 3rd. Coccidioidomycosis: epidemiology. Clin Epidemiol. 2013;25:185–97.
5.
go back to reference Galgiani JN. Coccidioidomycosis: a regional disease of national importance: rethinking approaches for control. Ann Intern Med. 1999;130:293–300.CrossRefPubMed Galgiani JN. Coccidioidomycosis: a regional disease of national importance: rethinking approaches for control. Ann Intern Med. 1999;130:293–300.CrossRefPubMed
10.
go back to reference US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute of Health. Biosafety in microbiological and biomedical laboratories, 6th edn. Government Printing Office, Washington. 2020. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute of Health. Biosafety in microbiological and biomedical laboratories, 6th edn. Government Printing Office, Washington. 2020.
15.
go back to reference Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis. 1982;4:656–64.CrossRefPubMed Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis. 1982;4:656–64.CrossRefPubMed
16.
go back to reference Cox RA, Baker BS, Stevens DA. Specificity of immunoglobulin E in coccidioidomycosis and correlation with disease involvement. Infect Immun. 1982;37:609–16.CrossRefPubMedPubMedCentral Cox RA, Baker BS, Stevens DA. Specificity of immunoglobulin E in coccidioidomycosis and correlation with disease involvement. Infect Immun. 1982;37:609–16.CrossRefPubMedPubMedCentral
17.
go back to reference Messina JA, Maziarz EK, Galgiani J, Truong JT, Htoo AK, Heidari A, et al. A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever). Contemp Clin Trials Commun. 2021;14(24): 100851.CrossRef Messina JA, Maziarz EK, Galgiani J, Truong JT, Htoo AK, Heidari A, et al. A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever). Contemp Clin Trials Commun. 2021;14(24): 100851.CrossRef
Metadata
Title
Surgical treatment for chronic pulmonary coccidioidomycosis: a retrospective study from a single institution
Authors
Hajime Tamura
Hidemi Suzuki
Takahiro Yamanaka
Taisuke Kaiho
Terunaga Inage
Takamasa Ito
Kazuhisa Tanaka
Yuichi Sakairi
Hironobu Wada
Ichiro Yoshino
Publication date
09-08-2023
Publisher
Springer Nature Singapore
Published in
Surgery Today / Issue 4/2024
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-023-02736-3

Other articles of this Issue 4/2024

Surgery Today 4/2024 Go to the issue